Andrew ElBardissi
InvestorPartner at Deerfield Management Company · Board director at Medical Micro Instruments · Board director at Aurion Biotech · Board director at Adelabio
New York, New York
Writes $10M – $50M checks · typically $25M
About
A partner on Deerfield's Medical Technologies team who joined in 2017, previously a principal at Longitude Capital investing in medtech and biotech and an associate in JPMorgan's healthcare investment banking practice. He is a trained surgeon with an M.D. from the Mayo Clinic, an M.P.H. and M.B.A. from Harvard, and residency training at Harvard's Brigham and Women's Hospital and Stanford.
Board director at Medical Micro Instruments
Intro paths
In turn, Andrew can intro founders to Medical Micro Instruments's investors below.
Medical Micro Instruments's investors · 4
Board director at Aurion Biotech
Intro paths
In turn, Andrew can intro founders to Aurion Biotech's investors below.
Aurion Biotech's investors · 3
Board director at Adelabio
Intro paths
In turn, Andrew can intro founders to Adelabio's investors below.
Adelabio's investors · 5
Co-founders at Adelabio
Experience
- Deerfield ManagementPartnercurrent2017 — presentNew York, New York, United States
- Medical Microinstruments, Inc.Board Membercurrent2022 — present
- Aurion BiotechBoard Membercurrent2022 — present
- BitterootBoard Membercurrent2021 — present
- Adela BioBoard Membercurrent2021 — present
- Encodia, Inc.Board Membercurrent2020 — present
- Endologix LLCBoard Membercurrent2020 — present
- Sema4Board Membercurrent2020 — present
- Reprieve CardiovascularBoard Membercurrent2020 — present
- Element Science, Inc.Board Membercurrent2019 — present
- Singular GenomicsBoard Membercurrent2018 — present
- Axon Therapies Inc.Board Membercurrent2018 — present
- InCarda TherapeuticsBoard Membercurrent2018 — present
- CathWorksBoard Membercurrent2018 — present
- Epic Sciences │ The Power of ClarityBoard Membercurrent2017 — present
- Sollis TherapeuticsBoard Membercurrent2017 — present
- Acutus Medical, Inc.Board Membercurrent2017 — present
- FARAPULSE, Inc.Board Membercurrent2017 — present
- V-WaveBoard Membercurrent2017 — present
- Conventus-Flower OrthopedicsBoard Membercurrent2017 — present
- NeoChord, Inc.Board Membercurrent2017 — present
- Longitude CapitalPrincipal2014 — 2017Menlo Park, CA
- Stanford University School of MedicineCardiothoracic Surgery Resident2012 — 2014Stanford, California
- J.P. MorganHealthcare Investment Banking Associate2011 — 2013New York, NY
- Harvard Medical SchoolBrigham and Women's Hospital Categorical General Surgery Resident2007 — 2012Boston, MA
Skills & more
+12 more
Market ResearchCompetitive AnalysisDue DiligenceFinancial AnalysisVenture CapitalInvestmentsMedical DevicesInvestment BankingClinical ResearchMergers & AcquisitionsStart-upsPrivate EquityFrom Andrew's professional profile.
Deals · 12
AdelabioBoard seat
via Deerfield Management Company · filed Jul 2025 · $27M raise
Medical Micro InstrumentsBoard seat
via Deerfield Management Company · filed Mar 2024 · $110M raise
NeochordBoard seat
via Deerfield Management Company · filed Nov 2022 · $6M raise
Acutus MedicalBoard seat
via Deerfield Management Company · filed Jul 2022 · $4.2M raise
Reprieve CardiovascularBoard seat
via Deerfield Management Company · filed Jun 2022 · $15M raise
Aurion BiotechBoard seat
via Deerfield Management Company · filed Apr 2022 · $26.1M raise
NXT BiomedicalBoard seat
via Deerfield Management Company · filed May 2021 · $10M raise
InCarda TherapeuticsBoard seat
via Deerfield Management Company · filed Oct 2020 · $50M raise
Element ScienceBoard seat
via Deerfield Management Company · filed Mar 2020 · $145.6M raise
Axon TherapiesBoard seat
via Deerfield Management Company · filed Feb 2019 · $15M raise
Conventus OrthopaedicsBoard seat
via Deerfield Management Company · filed Jan 2019 · $5M raise
Iowa ApproachBoard seat
via Deerfield Management Company · filed Aug 2018 · $12M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Deerfield Management Company
Network13
▶1 more connections
Investors connected to Andrew in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Andrew ElBardissi?
- A partner on Deerfield's Medical Technologies team who joined in 2017, previously a principal at Longitude Capital investing in medtech and biotech and an associate in JPMorgan's healthcare investment banking practice. He is a trained surgeon with an M.D. from the Mayo Clinic, an M.P.H. and M.B.A. from Harvard, and residency training at Harvard's Brigham and Women's Hospital and Stanford.
- Where does Andrew ElBardissi work?
- Andrew ElBardissi is Partner at Deerfield Management Company and Board director at Medical Micro Instruments and Board director at Aurion Biotech and Board director at Adelabio.
- What check size does Andrew ElBardissi write?
- Andrew ElBardissi typically writes checks of $10M – $50M.
- What boards does Andrew ElBardissi sit on?
- Andrew ElBardissi holds tracked board seats at Acutus Medical, Adelabio, Aurion Biotech, Axon Therapies, Conventus Orthopaedics, Element Science, InCarda Therapeutics, Iowa Approach, Medical Micro Instruments, Neochord.
- Where did Andrew ElBardissi go to school?
- Andrew ElBardissi studied at Harvard Business School (MBA, Business); Harvard T.H. Chan School of Public Health (MPH, Quantitative Methods); Mayo Clinic Alix School of Medicine (Doctor of Medicine (M.D.), Medicine).
Same school
Also attended Harvard Business School2,000
+ 1,994 more
Also attended Harvard T.H. Chan School of Public Health37
+ 31 more
Also attended Mayo Clinic Alix School of Medicine8
+ 2 more
Shared employers
Also worked at Medical Microinstruments, Inc.2
Also worked at Sema42
Also worked at V-Wave2
Also worked at Longitude Capital24
+ 18 more